Revvity, Inc. (RVTY)

Market Cap	14.05B
Revenue (ttm)	2.76B
Net Income (ttm)	270.39M
Shares Out	121.70M
EPS (ttm)	2.20
PE Ratio	49.88
Forward PE	23.17
Dividend	$0.28 (0.24%)
Ex-Dividend Date	Apr 17, 2025

Volume	35,521
Open	115.88
Previous Close	114.72
Day's Range	113.37 - 115.50
52-Week Range	97.32 - 129.50
Beta	1.03
Analysts	Buy
Price Target	137.73 (+19.35%)
Earnings Date	Jan 31, 2025

About RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its pro...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,500
• Stock Exchange: NYSE
• Ticker Symbol: RVTY
• Website: https://www.revvity.com

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Analyst Forecast

According to 11 analysts, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $137.73, which is an increase of 19.35% from the latest price.

Price Target

$137.73

(19.35% upside)

Analyst Consensus: Buy